Details for New Drug Application (NDA): 020105
✉ Email this page to a colleague
The generic ingredient in TRIOSTAT is liothyronine sodium. There are four drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the liothyronine sodium profile page.
Summary for 020105
Tradename: | TRIOSTAT |
Applicant: | Par Sterile Products |
Ingredient: | liothyronine sodium |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 0.01MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Dec 31, 1991 | TE: | RLD: | Yes |
Complete Access Available with Subscription